Neurostimulation devices market expected to double in value by 2030, driven by rising demand

From GlobeNewswire: 2025-03-28 08:25:00

The neurostimulation devices market is set to grow from $5.80 billion in 2022 to $11.82 billion by 2030, with a projected CAGR of 9.3% from 2022 to 2030. Factors driving growth include the rising prevalence of neurological disorders and spinal cord injuries.

Key players in the neurostimulation devices market include Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, and more. Trending topics in the market include Brain-Computer Interface (BCI) developments and Brain-Stimulation Headsets for Depression.

The global neurostimulation devices market is witnessing significant growth, with North America leading in revenue share in 2022. Asia Pacific is expected to register the highest CAGR during the forecast period.

Advancements in technology, rising prevalence of neurological conditions, and surging demand for nonsurgical treatment solutions are driving the growth of the neurostimulation devices market. Major growth drivers include advancements in brain stimulation technologies and growing adoption of neurostimulation devices in home settings.



Read more at GlobeNewswire: Neurostimulation Devices Market Set to Reach US$ 11.83